Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)
Clinical trial NCT02719990 · TERMINATED
Trial details
- NCT number
- NCT02719990
- Sponsor
- Versartis Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-11
- Primary completion
- 2018-01-11
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.